Word

MICROFOAM CHEMICAL ABLATION

Status

Dead

Status Code

602

Status Date

Tuesday, July 19, 2016

Serial Number

86531766

Mark Type

4000

Filing Date

Wednesday, February 11, 2015

Abandoned Date

Thursday, June 23, 2016

Trademark Owner History

Provensis Limited

Classifications

1 Chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disorders, particularly varicose veins; chemicals for use in the production of injectable foams

5 Pharmaceutical preparations in the form of foams for use in the treatment of sclerotherapy of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in the treatment of sclerotherapy of veins; pharmaceutical preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilization treatment or for treatment of varicose veins, or arterio-venous malformations

10 Cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams; surgical and medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical or medical apparatus for administering and producing foams for use in sterilization treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; devices for assessing the physical characteristics of such foams; devices for intravenous administration of foam and devices for monitoring the position and effect of foam in the human body; medical diagnostic devices for use in all the above medical conditions

41 Education, namely, developing, arranging and conducting educational conferences, seminars, workshops and programs and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; medical training; training in the use and operation of pharmaceutical products, pharmaceutical preparations; provision of educational classes and training in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; provision of educational classes and training in the field of health and medical information; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of healthcare, the use of pharmaceutical and medical devices, medical research, surgery, medical science, medicine and medical diseases, disorders and related treatments; Educational services, namely, providing non-downloadable webinars in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions and training in the field of health; educational services, namely, providing non-downloadable webinars in the field of health; education services, namely, conducting online and telephonic instruction and courses in the fields of health and medical issues

42 Scientific research services related to sclerotherapy of veins including provision of treatment in the fields of phlebology, proctology and angiology

44 Medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical health assessment services, namely, medical diagnostic testing, in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical treatment services in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical after-care services, namely, medical care services rendered after medical treatment and surgeries in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; providing health care information by telephone

Trademark Events

Jul 19, 2016

Abandonment Notice Mailed - Failure To Respond

Jul 19, 2016

Abandonment - Failure To Respond Or Late Response

Dec 22, 2015

Notification Of Final Refusal Emailed

Dec 22, 2015

Final Refusal E-Mailed

Dec 22, 2015

Final Refusal Written

Nov 24, 2015

Teas/Email Correspondence Entered

Nov 23, 2015

Correspondence Received In Law Office

Nov 23, 2015

Teas Response To Office Action Received

May 26, 2015

Notification Of Non-Final Action E-Mailed

May 26, 2015

Non-Final Action E-Mailed

May 26, 2015

Non-Final Action Written

May 18, 2015

Assigned To Examiner

Mar 5, 2015

Applicant Amendment Prior To Examination - Entered

Mar 4, 2015

Assigned To Lie

Feb 26, 2015

New Application Office Supplied Data Entered In Tram

Feb 24, 2015

Teas Voluntary Amendment Received

Feb 14, 2015

New Application Entered In Tram